Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Oct 17;193(5):948-958.
doi: 10.1093/bjd/ljaf277.

Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa

Affiliations
Meta-Analysis

Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa

K Alaine Broadaway et al. Br J Dermatol. .

Abstract

Background: Hidradenitis suppurativa (HS) is a common, chronic and debilitating inflammatory disease that most commonly affects intertriginous skin. Despite its high heritability, the genetic underpinnings of HS remain poorly understood.

Objectives: To identify genetic signals associated with HS, determine genetic relationships with other diseases and investigate potential molecular genetic mechanisms.

Methods: We performed a genome-wide association meta-analysis of six studies, totalling 4540 patients with HS and > 1 million control participants, and identified genetic correlations with other common diseases. We integrated the HS data with expression quantitative trait loci from 10 trait-relevant tissues, epigenomic and transcriptomic data from human scalp, differential expression data from HS lesions vs. adjacent skin and mesenchymal Hi-C chromatin looping data. To identify functional noncoding variants, we performed transcriptional reporter assays for signals near KLF5 and SOX9.

Results: We identified 11 significant HS signals across 7 loci: 4 corresponded to previously reported associations, 4 represented novel signals within known loci and 3 were signals in newly implicated loci. We identified significant genetic correlations between HS and other inflammatory conditions, particularly inflammatory bowel disease, rheumatoid arthritis, type 2 diabetes mellitus and asthma. We prioritized candidate genes for the 11 signals. The risk allele at KLF5 exhibited 10-fold greater transcriptional activity than the nonrisk allele, while risk alleles at SOX9 showed significantly reduced transcriptional activity.

Conclusions: Our results provide insights into potential genetic mechanisms underlying HS and suggest potential therapeutic targets for this challenging condition.

Plain language summary

Hidradenitis suppurativa is a chronic disease. It causes inflammation and painful damage to the skin, known as lesions. Lesions appear most commonly in areas where the skin rubs together, like the armpits. It is known as ‘HS’ for short. Although HS runs in some families, the genetic causes of the disease are not well known. To find out the genetic risk factors associated with HS, we analysed data from over 4500 people with the disease. We found 11 genetic signals linked to the disease. Four of these signals were already known, but seven were new. We also found genetic connections between HS and diseases like inflammatory bowel disease, rheumatoid arthritis, type 2 diabetes and asthma. To understand how these genetic signals might influence HS, we looked at gene activity in different types of skin cells and in HS lesions. Some signals may affect how the skin protects the body. Others may affect the body’s defence system. We also did experiments to test how DNA mutations in HS might affect genes. We found that genetic changes near genes called ‘KLF5’ and ‘SOX9’ can directly affect gene activity. These two genes are important for skin development and healing. Our findings provide new insights into the genetic basis of HS. They also suggest possible biological pathways involved in the disease. By understanding these genetic mechanisms, researchers can explore potential targets for future treatments. This will offer hope for improved therapies for people with the disease.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: C.J.S. is an investigator for AbbVie, Novartis, Incyte, InflaRx, UCB and AstraZeneca; a consultant for AbbVie, Novartis, Sanofi, Sandoz, AstraZeneca, Incyte, InflaRx, UCB, Navigator Medicines, Moonlake Immunotherapeutics and Alumis; a speaker for AbbVie, Novartis and UCB; and is the secretary of the HS Foundation. The other authors declare no conflicts of interest.

Figures

Graphical Abstract
Graphical Abstract
Figure 1
Figure 1
Hidradenitis suppurativa (HS) genetic association signals. (a) Manhattan plot of the associations between variants and HS in all populations. Variants within 1 Mb of a previously known HS locus are coloured in blue; variants within 1 Mb of a new HS locus (P ≤ 5 × 10–8) are coloured in red. Loci with asterisks (*) represent multi-signal loci. (b) Variant associations for new HS loci: (left) a signal near SUCNR1 was significantly associated with HS in the all-population analysis; (middle) a signal near NIN was significantly associated with HS in the EUR + AMR stratified analysis; (right) a signal near MXRA7 was significantly associated with HS in men. Chr, chromosome; EUR + AMR, European and admixed American populations.
Figure 2
Figure 2
Hidradenitis suppurativa locus detected in men-only genome-wide association studies (GWAS). (Left) Variants associated with HS in men (top) vs. women (bottom). (Right) Forest plot of men-only and women-only GWAS results. The MXRA7 locus is strong in men and shows consistent direction and strength of effect across all contributing studies. An effect is not detected in any women-only or sex-combined GWAS results. AFR, Black/African population; AoU, All of Us; EUR + AMR, European and admixed American populations; BioVU, BioVU project at Vanderbilt University Medical Center; Chr, chromosome; CI, confidence interval; MGBB, Mass General Brigham Biobank; ProCARE, Program for Research and Care Excellence; UKB, UK Biobank.
Figure 3
Figure 3
Genetic correlation between hidradenitis suppurativa and other complex traits. Green indicates Bonferroni significant correlations. IBD, inflammatory bowel disease; T2D, type 2 diabetes; PCOS, polycystic ovarian syndrome; RA, rheumatoid arthritis.
Figure 4
Figure 4
Differential expression of prioritized candidate genes in lesional vs. nonlesional tissue and in scalp cell types. We prioritized 20 genes that were within 100 kb of a lead variant, or the nearest protein-coding gene if none were within 100 kb, and genes with external evidence of relevance to hidradenitis suppurativa (HS). (Top) Log2 fold change (FC) of gene expression in HS lesional vs. matched nonlesional tissue. (Bottom) Log2 FC of gene expression in scalp cell types. Only increased expression in a cell type is shown. To be included, the cell type must be more highly expressed in at least one prioritized gene. Circles show the size of the fold change. Orange = keratinocytes; yellow = melanocytes; green = fibroblasts; purple = immune cells; brown = muscle or endothelial cells. Chr, chromosome
Figure 5
Figure 5
Hidradenitis suppurativa (HS) loci (left) KLF5 and (right) SOX9 may influence expression levels of their target genes in keratinocytes via a regulatory element that appears to be only accessible in keratinocytes. (Top row) Variant associations with HS for the two signals. (Middle left) Genome browser plots showing scalp chromatin accessibility by cell type. The lead variant of KLF5 (rs981625) is located in a keratinocyte-accessible regulatory element that was not seen in other examined cell types (chr13_73465564_73466065) and is strongly conserved across vertebrates. No other linkage disequilibrium (LD) proxies of the lead variant are located in accessible chromatin. KLF5 was more strongly expressed in keratinocytes than in any other cell type [log2fold change (FC) = 0.56–1.93 for keratinocyte cell clusters, P-values ≤ 4 × 10–166]. (Bottom left) The rs981625-C allele, which was associated with higher HS risk, showed 10-fold greater transcriptional activity than the rs981625-G reference allele (P = 2.9 × 10–7). (Middle right) The SOX9 lead variant rs17226067, and its LD proxies rs17825774 and rs17825799 (r2 = 1, shown in gold) are located in a region of open chromatin detected in keratinocytes but not in other surveyed cell types (chr17_71519287_71519788); no other LD proxies are located in accessible chromatin. SOX9 was also more highly expressed in hair follicle keratinocyte clusters than other scalp cell types (log2FC = 0.28–5.19, P-values ≤ 5 × 10–86). (Bottom right) The three-variant risk haplotype of rs17226067-G, rs17825774-A and rs17825799-A alleles showed more than twofold reduced transcriptional activity vs. the reference AGG haplotype (P = 0.001). cCRE, candidate cis-regulatory element; Chr, chromosome; EV, empty vector.
Figure 6
Figure 6
Both conditionally distinct signals on chromosome 9 exhibit a significant Hi-C chromatin interaction peak in mesenchymal data. (a) Variants associated with hidradenitis suppurativa (HS) at two conditionally distinct signals. (b) Mesenchymal cell Hi-C data anchored around rs1994799, the lead variant for the primary HS signal. (c) Mesenchymal cell Hi-C data anchored around rs1535620, the lead variant for the secondary HS signal. The target regions immediately flanking the anchor regions and target regions with FitHiC Q-values ≥ 0.01 are not shown. Arc colours are scaled by strength of association measured by –log10(P-value), with the darkest lines showing the link with the strongest P-value. Hi-C data in the red box, centred around KLF4, showed significant interactions; no significant interactions were observed around the more proximal gene ACTL7B (grey box). Chr, chromosome.

Comment in

References

    1. van Straalen KR, Prens EP, Willemsen G et al. Contribution of genetics to the susceptibility to hidradenitis suppurativa in a large, cross-sectional Dutch twin cohort. JAMA Dermatol 2020; 156:1359–62. - PMC - PubMed
    1. Kjaersgaard Andersen R, Clemmensen SB, Larsen LA et al. Evidence of gene-gene interaction in hidradenitis suppurativa: a nationwide registry study of Danish twins. Br J Dermatol 2022; 186:78–85. - PubMed
    1. Bruinsma RL, Fajgenbaum K, Yang Y et al. Assessment of familial risk in patients with hidradenitis suppurativa. Br J Dermatol 2021; 184:753–4. - PMC - PubMed
    1. Vinkel C, Thomsen SF. Hidradenitis suppurativa: causes, features, and current treatments. J Clin Aesthet Dermatol 2018; 11:17–23. - PMC - PubMed
    1. Garg A, Malviya N, Strunk A et al. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol 2022; 86:1092–101. - PMC - PubMed

Publication types

MeSH terms

Substances